Toggle navigation
Home
Search
Services
Blog
Contact
About
Total Synthesis of Antitumor Agent Octalactin A
Pedersen, Michelle L.
University of Pennsylvania, Philadelphia, PA, United States
Search grants from Michelle Pedersen
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Society for Prevention Research Annual Meetings
Cardivascular Health Programs
Mechanism of Induction of Malignant Gliomas
Cell Fate Determination in Early C Elegans Embryos
Using Natural Variation to Probe the Evolution, Mechanisms and Function of Imprinting in Plants
Recently added grants:
Genomic Insights into the Neurobiology of Cerebral Palsy
Alarmin-mediated control of CNS infection
Pharmacokinetic assessment of peptide-based therapy HV-3 for the treatment of Huntington's disease
Culturally relevant contributors to cognitive and MRI changes in older Latinos
Ultralong-term single-molecule imaging of amyloid precursor protein (APP) processing in Alzheimer's disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA072168-02
Application #
2545419
Study Section
Special Emphasis Panel (ZRG3-BNP (02))
Project Start
1997-10-01
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 1997
F32 CA
Total Synthesis of Antitumor Agent Octalactin A
Pedersen, Michelle L. / University of Pennsylvania
NIH 1996
F32 CA
Total Synthesis of Antitumor Agent Octalactin A
Pedersen, Michelle L. / University of Pennsylvania
Comments
Be the first to comment on Michelle Pedersen's grant